Medicure (MCUJF) Change in Receivables (2009 - 2026)
Medicure's (MCUJF) quarterly Change in Receivables came in at -$654826.7 in Q1 2026, down 212.26% year-on-year from $583319.1 in Q1 2025, and down 54.25% quarter-over-quarter from -$424515.1 in Q4 2025.
Medicure (MCUJF) Change in Receivables (2009 - 2026) Analysis & Trends
Medicure's Change in Receivables history runs 18 years deep, the most recent figure standing at -$654826.7 for Q1 2026.
- On a quarterly basis, Change in Receivables fell 212.26% year-over-year to -$654826.7 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 204.43% decrease from a year earlier, with the FY2025 full-year figure at $162468.8, up 48.29% from the prior year.
- Change in Receivables declined to -$654826.7 in Q1 2026 per MCUJF's latest filing, from -$424515.1 in the prior quarter.
- Across five years, Change in Receivables topped out at $595879.5 in Q2 2024 and bottomed at -$1.1 million in Q1 2022.
- The 5-year median for Change in Receivables is -$171204.4 (2022), against an average of -$133207.4.
- Biggest YoY gain for Change in Receivables was 455.44% in 2025; the steepest drop was 3388.37% in 2025.
- Year by year, Change in Receivables stood at -$218522.7 in 2022, then soared by 326.56% to $495076.9 in 2023, then tumbled by 102.46% to -$12169.4 in 2024, then sank by 3388.37% to -$424515.1 in 2025, then sank by 54.25% to -$654826.7 in 2026.
- Per Business Quant, the three latest MCUJF Change in Receivables figures stand at -$654826.7 (Q1 2026), -$424515.1 (Q4 2025), and $440340.8 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -654,826.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -654,826.71 |
| Mar 31, 2026 | -654,826.71 |
| Dec 31, 2025 | -424,515.08 |
| Dec 31, 2025 | -424,515.08 |
| Sep 30, 2025 | 440,340.81 |
| Sep 30, 2025 | 440,340.81 |
| Jun 30, 2025 | -450,348.60 |
| Jun 30, 2025 | -450,348.60 |
| Mar 31, 2025 | 583,319.09 |
| Mar 31, 2025 | 583,319.09 |
| Dec 31, 2024 | -12,169.44 |
| Dec 31, 2024 | -12,169.44 |
| Sep 30, 2024 | -123,886.03 |
| Sep 30, 2024 | -123,886.03 |
| Jun 30, 2024 | 595,879.55 |
| Jun 30, 2024 | 595,879.55 |
| Mar 31, 2024 | -355,472.23 |
| Mar 31, 2024 | -355,472.23 |
| Dec 31, 2023 | 495,076.95 |
| Dec 31, 2023 | 495,076.95 |